[1]Patent:WO2012/129564,2012,A2.Locationinpatent:Page/Pagecolumn143
[1]EuropeanJournalofMedicinalChemistry,2015,vol.96,p.1-13
1119451-10-3
10350-69-3
1820650-09-6
923694-00-2
1306606-52-9
143426-51-1 | [4-(1H-Pyrrol-1-yl)phenyl]methanol | AA007YTP | MFCD03659708
135362-69-5 | 3-[(4-Methoxybenzyl)oxy]-1-propanol | AA007ZJI | MFCD10570229
13412-64-1 | Dicloxacillin sodium salt monohydrate | AA008009 | MFCD00167147
13339-01-0 | Piperazine,1-(2-ethoxyphenyl)- | AA0080GF | MFCD01026120
118708-88-6 | 1-(4-(Trifluoromethyl)pyridin-2-yl)piperazine | AA0080WO | MFCD00114707
1189734-03-9 | [4-(5-Bromopyrimidin-2-yloxy)phenyl]methanol | AA0081GQ | MFCD09743713
113193-60-5 | Iron(II) Ethylenediammonium Sulfate Tetrahydrate | AA00829B | MFCD00082474
106827-26-3 | 5-(2,3-Dichlorophenyl)-2-furaldehyde | AA0082XG | MFCD00579046
108306-53-2 | 4-Bromo-2-(trimethylsilyl)thiazole | AA0083ME | MFCD01319107
1060816-58-1 | 5-Bromo-2-chloro-7h-pyrrolo[2,3-d]pyrimidine | AA0084BU | MFCD09909707